NOTCH3 and breast carcinoma: On the other hand, Notch3 is constitutively activated in one third of basal-like breast cancers, and a Notch3 specific antagonistic antibody, anti-N3.A4, hampered the growth of orthotopic HCC1143 breast cancer xenografts in mice [61].